Amandio Vieira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amandio Vieira has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Vai Hong Fong
Biomedical Physiology BPK, Simon Fraser University, Burnaby, BC, Canada
3 shared publicationsYu Yao
Metabolic and Endocrine Research Laboratory and IHRE, Applied Sciences K9600, Simon Fraser University, 8888 University Drive, Burnaby, BC, Canada V5A 1S6
3 shared publicationsShaun P. Wong
Metabolic Research Laboratory, Department of Biomedical Physiology BPK, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada
2 shared publicationsShaun Wong
Biomedical Physiology BPK, Simon Fraser University, Burnaby, BC, Canada
2 shared publicationsA. Guevara-Vásquez
Food, Metabolism, and Physiology Laboratory, Facultad de Farmacia y Bioquímica, Universidad Nacional de Trujillo, Trujillo 13008, Perú
1 shared publicationA. Vásquez-Arqueros
Food, Metabolism, and Physiology Laboratory, Facultad de Farmacia y Bioquímica, Universidad Nacional de Trujillo, Trujillo 13008, Perú
1 shared publication
Latest Publications
- 7 December 2022
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- Vol. 13 (6) , 437-444
Epigenetic regulation by metabolites from the gut microbiome
The gut microbiome can metabolise food components, such as dietary fibres and various phytochemicals; and the microbiome can also synthesise some nutrients, for example B vitamins. The metabolites produced by bacteria and other micro-organisms in the colon can have implications for health and disease risk. Some of these metabolites are epigenetically active, and can contribute to changes in the chemical modification and structure of chromatin by affecting the activity and expression of epigenetically-active enzymes, for example histone deacetylases and DNA methyltransferases. The epigenetic activity of such gut microbiome metabolites is reviewed herein.
- 7 December 2022
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- Vol. 13 (6) , 437-444
Epigenetic regulation by metabolites from the gut microbiome
The gut microbiome can metabolise food components, such as dietary fibres and various phytochemicals; and the microbiome can also synthesise some nutrients, for example B vitamins. The metabolites produced by bacteria and other micro-organisms in the colon can have implications for health and disease risk. Some of these metabolites are epigenetically active, and can contribute to changes in the chemical modification and structure of chromatin by affecting the activity and expression of epigenetically-active enzymes, for example histone deacetylases and DNA methyltransferases. The epigenetic activity of such gut microbiome metabolites is reviewed herein.
- 25 November 2019
- Published by Taylor & Francis in Endocrine Research
- Vol. 45 (2) , 131-136
Transport of the Thyroid Hormone Carrier Protein Transthyretin into Human Epidermoid Cells
Purpose: Transthyretin (TTR) is a protein with a growing number of biological functions in addition to its well-established binding and circulatory transport of thyroxine, and indirect retinoid transport through interaction with retinol-binding protein. Misfolded and aggregated wild-type and mutant TTRs are involved in amyloid diseases. Several aspects of TTR pathology and physiology remain poorly understood. Receptor-mediated cellular transport of TTR has been described in a few cell types; and such studies suggest the possibility of different TTR receptors and endocytic pathways. Our main objective was to further understand the endocytic pathways for TTR. Methods: In the current study, analyses of TTR endocytic transport were performed in the human A431 cell line. The results of TTR uptake were compared with those of the iron-carrier protein transferrin (Tf, a common stardard for endocytosis studies) in the same cell types. Results: A comparison of TTR and Tf endocytosis suggested similar early, 5–10 min, accumulation kinetics. But at a later time, 30 min, TTR accumulation was 20-30% lower than that of Tf (p < .05), a result that suggests different post-endocytic fates for these two ligands. Through the use of multiple endocytosis inhibitors, biochemical evidence is provided for an internalization pathway that differs from the clathrin-mediated endocytosis of Tf. Conclusions: These results for A431 cells are compared with others reported for different cell types; and it is suggested that this same hormone carrier protein can transit into cells through multiple endocytic pathways.
- 25 November 2019
- Published by Taylor & Francis in Endocrine Research
- Vol. 45 (2) , 131-136
Transport of the Thyroid Hormone Carrier Protein Transthyretin into Human Epidermoid Cells
Purpose: Transthyretin (TTR) is a protein with a growing number of biological functions in addition to its well-established binding and circulatory transport of thyroxine, and indirect retinoid transport through interaction with retinol-binding protein. Misfolded and aggregated wild-type and mutant TTRs are involved in amyloid diseases. Several aspects of TTR pathology and physiology remain poorly understood. Receptor-mediated cellular transport of TTR has been described in a few cell types; and such studies suggest the possibility of different TTR receptors and endocytic pathways. Our main objective was to further understand the endocytic pathways for TTR. Methods: In the current study, analyses of TTR endocytic transport were performed in the human A431 cell line. The results of TTR uptake were compared with those of the iron-carrier protein transferrin (Tf, a common stardard for endocytosis studies) in the same cell types. Results: A comparison of TTR and Tf endocytosis suggested similar early, 5–10 min, accumulation kinetics. But at a later time, 30 min, TTR accumulation was 20-30% lower than that of Tf (p < .05), a result that suggests different post-endocytic fates for these two ligands. Through the use of multiple endocytosis inhibitors, biochemical evidence is provided for an internalization pathway that differs from the clathrin-mediated endocytosis of Tf. Conclusions: These results for A431 cells are compared with others reported for different cell types; and it is suggested that this same hormone carrier protein can transit into cells through multiple endocytic pathways.
- 12 June 2018
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 14 (2) , 149-152
Modulation of a Cellular Transport Activity by Capsicum Extracts
- 12 June 2018
- Published by Bentham Science Publishers Ltd. in Current Bioactive Compounds
- Vol. 14 (2) , 149-152
Modulation of a Cellular Transport Activity by Capsicum Extracts
- 20 March 2018
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 18 (1) , 11-14
Endocytic Transport as a Drug Target in Infectious Diseases
Abstract: Components of the extracellular environment can be transported into cells by molecular mechanisms collectively termed endocytosis. Cells typically use a multitude of such internalization pathways. These endocytic transport pathways have a wide range of implications for physiological regulation as well as pathological processes. Many infectious diseases, for example, involve internalization of the pathogen into the cell as part of the infection process. Selective interference with the endocytic transport of a microbe, thus, represents a therapeutic strategy that may prevent infections or decrease the rate of their progression. Herein, we provide a brief review of strategies for discovery of novel anti-infection drugs and their pharmacological implications.
- 20 March 2018
- Published by Bentham Science Publishers Ltd. in Infectious Disorders - Drug Targets
- Vol. 18 (1) , 11-14
Endocytic Transport as a Drug Target in Infectious Diseases
Abstract: Components of the extracellular environment can be transported into cells by molecular mechanisms collectively termed endocytosis. Cells typically use a multitude of such internalization pathways. These endocytic transport pathways have a wide range of implications for physiological regulation as well as pathological processes. Many infectious diseases, for example, involve internalization of the pathogen into the cell as part of the infection process. Selective interference with the endocytic transport of a microbe, thus, represents a therapeutic strategy that may prevent infections or decrease the rate of their progression. Herein, we provide a brief review of strategies for discovery of novel anti-infection drugs and their pharmacological implications.
- 1 April 2017
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 85, 102-105
Disruption of endocytic transport by transthyretin aggregates
- 1 April 2017
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 85, 102-105
Disruption of endocytic transport by transthyretin aggregates
- 1 December 2015
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 76, 6-10
Activities of apocynin in cytotoxicity assays of potential pathological relevance
- 1 December 2015
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 76, 6-10
Activities of apocynin in cytotoxicity assays of potential pathological relevance
- 27 October 2010
- Published by Taylor & Francis in Natural Product Research
- Vol. 24 (18) , 1726-1733
Comparative antioxidant activities and synergism of resveratrol and oxyresveratrol
Resveratrol (1) and oxyresveratrol (2) are phytoalexins with antioxidant activities (AAs) and proposed effects against several pathological processes. The main objective of this study was to provide a novel, comparative assessment of their AAs, and to test for potential synergism in their combined activities, or in combination with another phytochemical antioxidant, curcumin (3). The phytochemicals were tested at 10 µM total concentrations in a heme-based assay that involved, as the final step, quantification of tetramethyl-phenylene-diamine oxidation. Significant AAs were observed for both 1 and 2, 27–33% inhibition of oxidation (p < 0.05 relative to non-phytochemical control). The combination of 1 and 2 in the same assay (5 µM each) suggested a moderate synergistic effect of about 10% (41% inhibition of oxidation by 1/2 under the same conditions as for 1 and 2 separately). Combinations of 1/3 and 2/3 were also synergistic, but 1/3 had a two-fold greater AA (p < 0.05) than 2/3 (or 1/2). Our results indicate that (i) 1 and 2 are effective antioxidants in the assay, (ii) in combination, their AAs can synergise, and (iii) in relation to 2, 1 has a much greater synergistic potential with 3. The latter suggests different synergy mechanisms of the curcuminoid with each of the two stilbene phytoalexins.
- 27 October 2010
- Published by Taylor & Francis in Natural Product Research
- Vol. 24 (18) , 1726-1733
Comparative antioxidant activities and synergism of resveratrol and oxyresveratrol
Resveratrol (1) and oxyresveratrol (2) are phytoalexins with antioxidant activities (AAs) and proposed effects against several pathological processes. The main objective of this study was to provide a novel, comparative assessment of their AAs, and to test for potential synergism in their combined activities, or in combination with another phytochemical antioxidant, curcumin (3). The phytochemicals were tested at 10 µM total concentrations in a heme-based assay that involved, as the final step, quantification of tetramethyl-phenylene-diamine oxidation. Significant AAs were observed for both 1 and 2, 27–33% inhibition of oxidation (p < 0.05 relative to non-phytochemical control). The combination of 1 and 2 in the same assay (5 µM each) suggested a moderate synergistic effect of about 10% (41% inhibition of oxidation by 1/2 under the same conditions as for 1 and 2 separately). Combinations of 1/3 and 2/3 were also synergistic, but 1/3 had a two-fold greater AA (p < 0.05) than 2/3 (or 1/2). Our results indicate that (i) 1 and 2 are effective antioxidants in the assay, (ii) in combination, their AAs can synergise, and (iii) in relation to 2, 1 has a much greater synergistic potential with 3. The latter suggests different synergy mechanisms of the curcuminoid with each of the two stilbene phytoalexins.
- Open Access
- 1 June 2010
- Published by Walter de Gruyter GmbH in Interdisciplinary Toxicology
- Vol. 3 (2) , 82-85
A meta-analysis of medicinal plants to assess the evidence for toxicity
A meta-analysis of medicinal plants to assess the evidence for toxicity: Toxicity of phytochemicals, plant-based extracts and dietary supplements, and medicinal plants in general, is of medical importance and must be considered in phytotherapy and other plant uses. We show in this report how general database analyses can provide a quantitative assessment of research and evidence related to toxicity of medicinal plants or specific phytochemicals. As examples, several medicinal plants are analyzed for their relation to nephrotoxicity and hepatotoxicity. The results of analyses in different databases are similar, and reveal the two best-established toxic effects among the group of plants that were examined: nephrotoxicity ofAristolochia fangchiand hepatotoxicity ofLarrea tridentata.
- 1 June 2010
- Published by Walter de Gruyter GmbH in Interdisciplinary Toxicology
- Vol. 3 (2) , 82-85
Open AccessA meta-analysis of medicinal plants to assess the evidence for toxicity
A meta-analysis of medicinal plants to assess the evidence for toxicity: Toxicity of phytochemicals, plant-based extracts and dietary supplements, and medicinal plants in general, is of medical importance and must be considered in phytotherapy and other plant uses. We show in this report how general database analyses can provide a quantitative assessment of research and evidence related to toxicity of medicinal plants or specific phytochemicals. As examples, several medicinal plants are analyzed for their relation to nephrotoxicity and hepatotoxicity. The results of analyses in different databases are similar, and reveal the two best-established toxic effects among the group of plants that were examined: nephrotoxicity ofAristolochia fangchiand hepatotoxicity ofLarrea tridentata.
- Open Access
- 11 January 2010
- Published by Cambridge University Press (CUP) in Public Health Nutrition
- Vol. 13 (9) , 1403-1409
Flavonoid intake and disability-adjusted life years due to Alzheimer’s and related dementias: a population-based study involving twenty-three developed countries
Objective: Dietary flavonoids and their metabolites may have neuroprotective effects against age-associated neurodegenerative disorders such as Alzheimer’s and related dementias (dementia). There is a lack of population studies, however, on correlations between flavonoid intake and dementia. The main objective of the present study was to analyse such a relationship at a large-scale population level.Design: Based on global data (FAO, WHO), databases were generated for: (i) flavonoid content of foods; (ii) per capita national dietary intakes of flavonoids and other dietary factors; and (iii) disability-adjusted life years – a measure of burden and death – due to dementia. Five major flavonoid subclasses were examined. To minimize influences due to accuracy and reliability of the disease source data, twenty-three developed countries were selected after statistical evaluation.Results: Flavonols and combined flavonoids (all five combined) intakes were the only two parameters with significant (P < 0·05) negative dementia correlations. Multiple linear regression models confirmed this relationship, and excluded confounding from some other dietary and non-dietary factors. Similar analyses with non-dementia, neurological/psychiatric diseases did not yield significant correlations.Conclusions: At a global level, and in the context of different genetic backgrounds, our results suggest that higher consumption of dietary flavonoids, especially flavonols, is associated with lower population rates of dementia in these countries.
- 11 January 2010
- Published by Cambridge University Press (CUP) in Public Health Nutrition
- Vol. 13 (9) , 1403-1409
Open AccessFlavonoid intake and disability-adjusted life years due to Alzheimer’s and related dementias: a population-based study involving twenty-three developed countries
Objective: Dietary flavonoids and their metabolites may have neuroprotective effects against age-associated neurodegenerative disorders such as Alzheimer’s and related dementias (dementia). There is a lack of population studies, however, on correlations between flavonoid intake and dementia. The main objective of the present study was to analyse such a relationship at a large-scale population level.Design: Based on global data (FAO, WHO), databases were generated for: (i) flavonoid content of foods; (ii) per capita national dietary intakes of flavonoids and other dietary factors; and (iii) disability-adjusted life years – a measure of burden and death – due to dementia. Five major flavonoid subclasses were examined. To minimize influences due to accuracy and reliability of the disease source data, twenty-three developed countries were selected after statistical evaluation.Results: Flavonols and combined flavonoids (all five combined) intakes were the only two parameters with significant (P < 0·05) negative dementia correlations. Multiple linear regression models confirmed this relationship, and excluded confounding from some other dietary and non-dietary factors. Similar analyses with non-dementia, neurological/psychiatric diseases did not yield significant correlations.Conclusions: At a global level, and in the context of different genetic backgrounds, our results suggest that higher consumption of dietary flavonoids, especially flavonols, is associated with lower population rates of dementia in these countries.